Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc. (LIXT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LIXT · as of Jun 9, 2026
Key Statistics
Explore Lixte Biotechnology Holdings, Inc. Data
lixt stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
lixt competitorsLIXT
ALLR
BCTX
CASI
CING
CLSDStock Performance
Full HistoryAbout Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc. is a drug discovery company focused on developing new treatments. It employs biomarker technology to identify crucial enzyme targets associated with serious, widespr…
what is lixte biotechnology holdings, inc. · lixt stock overview · lixte biotechnology holdings, inc. company profile · who is lixte biotechnology holdings, inc. ceo · lixt NASDAQ · lixte biotechnology holdings, inc. headquarters · lixte biotechnology holdings, inc. business segments
About Stock Overview & Key Data
Lixte Biotechnology Holdings, Inc. (LIXT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 25, 2007. As of the latest trading session, LIXT stock price is $6.65, with a market capitalization of $82.3M. The stock has returned +432.00% over the past 12 months and +69.21% year-to-date.
In fiscal year 2025, Lixte Biotechnology Holdings, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lixte Biotechnology Holdings, Inc. (LIXT) stock price is $6.65. The stock is traded on NASDAQ under the ticker symbol LIXT. The 52-week range is $0.64 – $7.50.